We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LEXX market cap is 33.3M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 101k | 35k | 94k | -4k | 151k |
| Operating Income | -1.77M | -1.31M | -2.38M | -1.07M | -1.14M |
| Net Income | -1.76M | -1.3M | -2.37M | -1.24M | -1.18M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 222k | 384k | 726k | 255k | 226k |
| Operating Income | -4.13M | -1.4M | -5.71M | -7.38M | -6.53M |
| Net Income | -4.1M | -4.23M | -4.03M | -7.27M | -6.67M |
| Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.21M | 4.86M | 5.24M | 3.08M | 3.63M |
| Total Liabilities | 281k | 223k | 1.2M | 404k | 254k |
| Total Equity | 5.93M | 4.63M | 4.04M | 2.68M | 3.37M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.68M | 2.83M | 13.27M | 7.83M | 3.08M |
| Total Liabilities | 185k | 346k | 203k | 201k | 404k |
| Total Equity | 2.49M | 2.48M | 13.06M | 7.63M | 2.68M |
| Quarter End | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.23M | -2.47M | -4.26M | -5.88M | -1.18M |
| Investing | -35k | -67k | -101k | -170k | -40k |
| Financing | -11k | N/A | 1.71M | 1.59M | 1.82M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.01M | -2.66M | -3.99M | -4.88M | -5.88M |
| Investing | -768k | -27k | 194k | -180k | -170k |
| Financing | 3.33M | 2.7M | 13.42M | -45k | 1.59M |
| Market Cap | 33.3M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 10.28M |
| Average Volume (1 week) | 298.64k |
| Average Volume (1 Month) | 215.38k |
| 52 Week Change | 81.01% |
| 52 Week High | 6.85 |
| 52 Week Low | 0.6488 |
| Spread (Intraday) | 0.23 (7.01%) |
| Company Name | Lexaria Bioscience Corporation |
| Address |
100-740 mccurdy rd kelowna, british columbia V1X 2P7 |
| Website | https://lexariabioscience.com |
| Industry | crude petroleum & natural gs (1311) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
